Resource

 

 

 

 

 

 

 

 

 

 

 

Norton Rose Fulbright advises on Aquiline Capital Partners' sale of its interest in Beach & Associates

20 Jan 2018

Global law firm Norton Rose Fulbright has advised Aquiline Capital Partners (Aquiline) on the sale of its interest in London-based broker Beach & Associates (Beach) to Acrisure LLC (Acrisure). Acrisure has agreed to acquire 100 percent of Beach’s equity from existing shareholders, which include Aquiline as well as current and previous Beach management.

McDermott Advises Mitsubishi Heavy Industries in Connection with the Reorganization of the French Nuclear Industry

20 Jan 2018

PARIS (January 18, 2018) – International law firm McDermott Will & Emery has advised Mitsubishi Heavy Industries in connection with its participation in the reorganization of the French nuclear industry.

McDermott counseled Mitsubishi Heavy Industries in acquiring a minority stake in Framatome (formerly known as New NP), an entity that brings together the assets of the Areva group relating to the design, supply and sale of equipment, fuel assemblies and services for nuclear reactors.

Osborne Clarke advises Cloud Savings Company on MBO of Vouchercloud & Giftcloud

20 Jan 2018

International legal practice Osborne Clarke has advised the senior management team of Cloud Savings Company Limited on its acquisition of Invitation Digital Limited (“IDL”), owner and operator of the Vouchercloud and Giftcloud brands, following a management buy-out from the Vodafone Group, placing the company back in the hands of its original founders, Scott Davidson and Greg Le Tocq.

MinterEllison guides sale of Nucleus Network to Crescent Capital Partners

20 Jan 2018

MinterEllison has advised the Baker Heart and Diabetes Institute on the sale of 100% of clinical research company Nucleus Network Limited to private equity firm Crescent Capital Partners.

Based in Melbourne, the Nucleus Network is Australia’s leading early phase clinical research facility. It was established in 2003 and employs more than 100 employees, conducting trials for a range of global biotechnology and pharmaceutical clients.

The sale will boost the Victorian and Australian biotechnology and medical research sectors.

Greenberg Traurig Germany advises Quest on the acquisition of the “Lenzhaus” in Berlin

20 Jan 2018

Berlin, January 18, 2018 – Greenberg Traurig Germany advised Quest Investment Partners (Quest) on the acquisition of the “Lenzhaus” office property in Berlin. It was sold by Barings Real Estate Advisers, who had acquired the property for an individual fund of a German pension fund in 2015. The parties agreed to keep the purchase price confidential.

Slaughter and May advised Premier Oil plc on US$205 million accelerated exchange of convertible bonds

20 Jan 2018

Slaughter and May advised Premier Oil plc on its successful invitation to convertible bondholders to accelerate the exchange of their outstanding convertible bonds into ordinary shares of the company.  87.5% (US$205.78 million) of the US$235.2 million convertible bonds outstanding were accepted for early conversion under the invitation, which was launched on 11 January and completed on 16 January 2018.  The benefits to the company and its shareholders include reduction of the company’s indebtedness by US$ 205.78 million, increased stability in the company’s capital bas

Bryan Cave Advises Ufenau Capital Partners on Acquisition of Pferdeklinik Großwallstadt by Altano Group

20 Jan 2018

Pfäffikon (Switzerland)/Frankfurt, Jan. 18, 2018 – A Bryan Cave M&A team, led by Frankfurt Office Managing Partner Tobias Fenck, recently advised Altano Group, a corporation of the Swiss holding company Ufenau Capital Partners, on the acquisition of Tierärztliche Klinik für Pferde Großwallstadt. As one of the leading horse clinic operators, Altano Group will strengthen its presence in the Rhine-Main area through this acquisition. This is one of three acquisitions by Altano in the last six months.